Literature DB >> 3817069

Interaction between isoniazid and theophylline.

P Höglund, L G Nilsson, O Paulsen.   

Abstract

Metabolic interactions between theophylline and several other drugs have been described in a number of studies. They may be of importance because of the narrow therapeutic range of theophylline. A significant risk for interactions has been considered to exist only with drugs metabolized by oxidative enzyme systems, and thus is not expected to occur with isoniazid. However, an increased clearance of theophylline with oral isoniazid medication has been reported. On the other hand, we found a significant increase in plasma levels of intravenously infused theophylline, and a corresponding decrease in plasma clearance of theophylline, when isoniazid was administered orally, compared to similar infusions in these individuals without concomitant isoniazid medication. The effect was seen irrespective of acetylator status. In five of the seven subjects an increase of isoniazid half-life and AUC was seen with theophylline, but this increase was not statistically significant.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3817069

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  6 in total

Review 1.  Pharmacokinetic interactions between theophylline and other medication (Part II).

Authors:  R A Upton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

2.  Theophylline and isoniazid.

Authors:  J R Thompson; T H Self
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

3.  Lowering of theophylline clearance by isoniazid in slow and rapid acetylators.

Authors:  B Santoso
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

Review 4.  Clinically significant interactions with drugs used in the treatment of tuberculosis.

Authors:  W W Yew
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 5.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

6.  Pharmacokinetics of isoniazid in low-birth-weight and premature infants.

Authors:  A Bekker; H S Schaaf; H I Seifart; H R Draper; C J Werely; M F Cotton; A C Hesseling
Journal:  Antimicrob Agents Chemother       Date:  2014-02-03       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.